Welltower (WELL) Stock Looks Fully Priced With Strong Cash Flow But Rich Earnings
Welltower stock has delivered a very strong 211.3% total return over the past 5 years, yet current checks suggest it is no longer an obvious bargain. The Discounted Cash Flow (DCF) estimate points to a roughly fair price, while market multiples lean expensive.
- Welltower's 211.3% return over 5 years highlights how much of the long term value story may already be reflected in the share price.
- Expectations for resilient cash flows from healthcare real estate can support the current valuation, while interest rate sensitivity and funding needs for future investment may weigh on how much further investors are willing to pay.
- On Simply Wall St's broader valuation checks, Welltower scores 0 out of 6, which points to a stock that leans expensive rather than a clear bargain.
The issue now is whether Welltower's current price around US$234.44 still leaves enough potential upside to justify that richer valuation backdrop.
Where Does Welltower Sit on Cash Flow?
The Discounted Cash Flow (DCF) model for Welltower uses adjusted funds from operations to estimate what today’s cash flows are worth. On this approach, the company’s latest twelve month free cash flow sits at about $1.82b, with analysts expecting growing cash flows over time rather than a shrinking profile.
Rolling those projections together, the DCF model points to an intrinsic value of about $219 per share, compared with the current share price around $234. That implies the stock trades roughly 7.2% above the DCF estimate, so Welltower currently screens as slightly overvalued rather than clearly cheap.
On this cash flow view, Welltower appears roughly fairly valued with a slight tilt toward overvalued territory.
Welltower is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.
Does Welltower Look Pricey on Earnings?
P/E is a useful anchor for Welltower because earnings remain a core yardstick for how the market prices this health care REIT. On this metric, Welltower trades on a P/E of about 109.0x, which is far above the Health Care REITs industry average of roughly 18.2x and above the broader peer group average of about 87.9x.
The fair P/E that the model suggests for Welltower is about 39.5x, which is much lower than the current 109.0x. The gap indicates that investors are paying a substantial premium to what the model identifies as a more balanced earnings multiple, even after considering the company’s scale, sector and risk profile.
On the P/E multiple, Welltower stock currently appears overvalued compared with both its indicated fair ratio and sector benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
The Welltower Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Welltower pick up where this valuation puzzle leaves off by spelling out what would need to happen to Welltower's growth, margins and earnings for the stock to be worth meaningfully more or less than today’s price. Each narrative links a specific fair value view to a clear storyline about potential catalysts and risks, so you can track over time which version of Welltower's future appears to be taking shape. Narratives sit on Simply Wall St's Community page and give you a structured way to think about what is already priced in.
Community views on Welltower sit on a knife edge, with one side seeing long term tailwinds and the other focused on valuation and income trade offs.
Bull case: roughly fairly valued
"The deployment of the Welltower Business System is aimed at reducing costs and increasing efficiency, potentially leading to improved net margins and earnings over the long term..."
Read the full Bull Case to see why Welltower could be undervalued
Bear case: roughly fairly valued
"Rising interest rates can increase financing costs and compress valuation multiples across the REIT sector..."
Read the full Bear Case to see why Welltower could be overvalued
Do you think there's more to the story for Welltower? Head over to our Community to see what others are saying!
The Bottom Line
For Welltower, the Discounted Cash Flow (DCF) intrinsic value estimate suggests the stock sits a little above what its projected cash flows might justify, while the P/E multiple points more clearly to an overvalued profile versus peers and a lower implied fair ratio. Broader checks also sit in the weaker tier on value, which reinforces the idea that this is not a clear-cut bargain. The real swing factor from here is whether the market continues to support a rich multiple for Welltower in light of its cash flow resilience and interest rate sensitivity, or whether expectations cool and the valuation settles closer to intrinsic value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com